MedTrace Logo

Coronary and Heart Effects of Early Treatment in Familial Hypercholesterolemia

NCT05352386 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 135

Last updated 2023-03-14

No results posted yet for this study

Summary

This study evaluates plaque burden and characteristics in early-treated FH patients compared to late-treated FH patients and healthy individuals.

Conditions

  • Familial Hypercholesterolemia

Interventions

DIAGNOSTIC_TEST

Coronary computed tomography angiography (CCTA)

Participants undergo coronary computed tomography angiography (CCTA)

Sponsors & Collaborators

  • Dutch Heart Foundation

    collaborator OTHER

  • Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-03-07
Primary Completion
2022-12-19
Completion
2022-12-19

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05352386 on ClinicalTrials.gov